Two female patients, 26 and 39 years of age, had ventricular fibrillation that required an
automatic implantable cardioverter defibrillator (AICD) and recovered.
The VENTAK[R] PRIZM 2[R] AICD
automatic implantable cardioverter defibrillators are designed to detect and terminate ventricular tachycardia (VT) and ventricular fibrillation (VF), as well as provide bradycardia therapy (atrial and/or ventricular pacing).
Automatic implantable cardioverter defibrillators have been shown to reduce deaths in heart failure patients with prior sudden death or malignant ventricular arrhythmias.
Psychiatric morbidity following implantation of the
automatic implantable cardioverter defibrillator.
The
Automatic Implantable Cardioverter Defibrillator (AICD) is a small electronic device that is implanted in patients at high risk for sudden cardiac death due to ventricular arrhythmias.